Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.26 CNY
−189.45 M CNY
3.88 B CNY
442.77 M
About NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL
Sector
CEO
Yong Qun Tang
Headquarters
Nanjing
Website
Founded
2000
ISIN
CNE100002WP3
FIGI
BBG00CLB4S18
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. is a holding company that engages in the research, development, manufacture and sale of biochemical pharmaceutical products. It offers injections such as heparin sodium, low molecular weight heparin, and heparin sodium raw material. The company was founded on October 16, 2000 and is headquartered in Nanjing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 603707 is 13.73 CNY — it has decreased by −4.19% in the past 24 hours. Watch NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL stocks are traded under the ticker 603707.
603707 stock has fallen by −7.35% compared to the previous week, the month change is a −9.31% fall, over the last year NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL has showed a −1.15% decrease.
We've gathered analysts' opinions on NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL future price: according to them, 603707 price has a max estimate of 20.85 CNY and a min estimate of 16.00 CNY. Watch 603707 chart and read a more detailed NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL stock forecast: see what analysts think of NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL and suggest that you do with its stocks.
603707 reached its all-time high on Aug 7, 2020 with the price of 35.52 CNY, and its all-time low was 2.80 CNY and was reached on Jul 19, 2017. View more price dynamics on 603707 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
603707 stock is 4.97% volatile and has beta coefficient of 0.68. Track NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL there?
Today NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL has the market capitalization of 22.18 B, it has decreased by −2.72% over the last week.
Yes, you can track NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL is going to release the next earnings report on Apr 25, 2025. Keep track of upcoming events with our Earnings Calendar.
603707 net income for the last quarter is 200.77 M CNY, while the quarter before that showed 227.83 M CNY of net income which accounts for −11.88% change. Track more NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL financial stats to get the full picture.
Yes, 603707 dividends are paid annually. The last dividend per share was 0.10 CNY. As of today, Dividend Yield (TTM)% is 0.73%. Tracking NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL dividends might help you take more informed decisions.
As of Nov 24, 2024, the company has 1.45 K employees. See our rating of the largest employees — is NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL on this list?
Like other stocks, 603707 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL stock shows the neutral signal. See more of NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.